Triple Negative Metastatic Breast Cancer Research Update - 2025-2026 EMBRACE MBC Virtual Forum Series
Dana-Farber Cancer Institute via YouTube
Overview
Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Learn about the latest advances in research and treatment for patients with triple negative metastatic breast cancer in this 55-minute virtual forum presentation. Discover cutting-edge developments in therapeutic approaches, clinical trial findings, and emerging treatment strategies specifically targeting triple negative metastatic breast cancer from leading oncologists Dr. Filipa Lynce and Dr. Ana Garrido-Castro. Gain insights into current research directions, novel drug combinations, immunotherapy applications, and personalized treatment approaches that are shaping the future of care for this challenging breast cancer subtype. Explore how recent scientific breakthroughs are translating into improved outcomes and quality of life for patients living with triple negative metastatic breast cancer, while understanding the unique characteristics that distinguish this subtype from other forms of breast cancer.
Syllabus
Triple Negative MBC Research Update | 2025-2026 EMBRACE MBC Virtual Forum Series
Taught by
Dana-Farber Cancer Institute